| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,112 | 1,194 | 16.12. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.11. | Modulight Biotherapeutics: $12.2 Million Seed Round Raised To Pioneer Light-Based Therapies For Neurological Disorders | 2 | pulse2.com | ||
| 12.11. | Modulight secures $12m to shine precise light on neurological diseases | 1 | Pharmaceutical Technology | ||
| 12.11. | Modulight Biotherapeutics Raises $12M in Seed Funding | 1 | FinSMEs | ||
| 24.10. | Modulight Oyj: Continued Improvement in Revenue and Profitability | 125 | GlobeNewswire (Europe) | Modulight Corporation | Company Release | October 24, 2025 at 13:00:00 EEST
This release is a summary of Modulight's interim report for January-September 2025. The whole report is attached to this stock... ► Artikel lesen | |
| 22.08. | Modulight Oyj: Revenue and profitability improved in line with the strategy | 235 | GlobeNewswire (Europe) | Modulight Corporation | Company Release | August 22, 2025 at 13:00:00 EEST
This release is a summary of Modulight's half-year financial report for January-June 2025. The whole report is attached to... ► Artikel lesen | |
| MODULIGHT Aktie jetzt für 0€ handeln | |||||
| 25.04. | Modulight Oyj: Revenue Increased and Profitability Improved | 356 | GlobeNewswire (Europe) | Modulight Corporation | Company Release | April 25, 2025 at 13:00:00 EEST
This release is a summary of Modulight's 1Q25 interim report. The whole report is attached to this stock exchange release as... ► Artikel lesen | |
| 21.02. | Modulight Oyj: Strong order intake and cost reductions improved cash flow despite increased R&D investments | 234 | GlobeNewswire (Europe) | Modulight Corporation | Company Release | February 21, 2025 at 13:00:00 EET
This release is a summary of Modulight's financial statements bulletin 2024. The whole report is attached to this stock... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 14,810 | -1,46 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| THERMO FISHER | 483,35 | -0,41 % | Dividendenbekanntmachungen (15.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A&W FOOD SERVICES OF CANADA INC CA0002251027 0,48 CAD 0,2969 EUR AMERICAN HOMES 4 RENT US02665T3068 0,3 USD 0,2555 EUR ARES CAPITAL... ► Artikel lesen | |
| VIVANI MEDICAL | 1,170 | -3,31 % | Vivani Medical, Inc.: Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results | Company plans to initiate Phase 1 clinical study of semaglutide implant for chronic weight management in the first half of 2026 and parallel investments in studies to enable rapid initiation of Phase... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,210 | -0,38 % | Aktien Frankfurt Ausblick: Dax dürfte vor US-Zinsentscheidung leicht schwächeln | FRANKFURT (dpa-AFX) - Vor der US-Leitzinsentscheidung an diesem Abend dürften die Anleger am deutschen Aktienmarkt einen Gang herunterschalten. Der Dax wurde rund eine Stunde vor Beginn des Börsenhandels... ► Artikel lesen | |
| FRESENIUS | 47,430 | -2,21 % | AKTIEN IM FOKUS: Medizintechnikwerte von Exane bewegt - 'Zweigeteiltes 2026' | FRANKFURT (dpa-AFX) - Die Aktien von Siemens Healthineers und Sartorius haben am Mittwoch nach einer Studie von Exane BNP Paribas zum europäischen Medizintechniksektor unterschiedliche Richtungen eingeschlagen.... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,180 | +0,53 % | FMC, Hugo Boss, Kontron, PVA TePla, Suss MicroTec, TeamViewer - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 36,440 | +1,33 % | BrightSpring upgraded at KeyBanc on specialty pharmacy and EBITDA prospects | ||
| GENEDX | 141,66 | 0,00 % | GeneDx and Guardant Health named as BTIG's top picks for 2026 | ||
| CARL ZEISS MEDITEC | 39,940 | -0,45 % | EQS-News: Carl Zeiss Meditec AG: Carl Zeiss Meditec schließt das Geschäftsjahr 2024/25 mit solidem Umsatzwachstum und einem leichten Anstieg des EBITA ab | EQS-News: Carl Zeiss Meditec AG
/ Schlagwort(e): Jahresergebnis/Jahresbericht
Carl Zeiss Meditec schließt das Geschäftsjahr 2024/25 mit solidem Umsatzwachstum und einem leichten... ► Artikel lesen | |
| HEARTBEAM | 3,435 | 0,00 % | Heartbeam stock is a buy, this analyst says | ||
| ALIGNMENT HEALTHCARE | 20,030 | -0,40 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| GERRESHEIMER | 27,060 | -3,77 % | Bitcoin Group, Gerresheimer, Hugo Boss, Lanxess, Nagarro, Puma, Renk - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| BETA BIONICS | 29,630 | -0,30 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| CLEARPOINT NEURO | 13,820 | +11,63 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Completes Acquisition of IRRAS | Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire... ► Artikel lesen | |
| LUMEXA IMAGING | 17,830 | -3,73 % | Lumexa Imaging Announces Pricing of Initial Public Offering | RALEIGH, N.C., Dec. 10, 2025 /PRNewswire/ -- Lumexa Imaging Holdings, Inc. ("Lumexa Imaging") announced today the pricing of its initial public offering of 25,000... ► Artikel lesen |